Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Alexion Pharmaceuticals (ALXN) numbers raised at Citigroup. Shares of ALXN now seen reaching $79. Estimates also increased, to match the company's new guidance. Buy rating.
Alexion Pharmaceuticals (ALXN) downgraded at Jefferies from Buy to Hold. Valuation call, based on a $69 price target.Digital Realty Trust (DLR) initiated at Barclays with an Overweight rating and $72 price target. Data centers will benefit from strong secular demand growth in the coming years. F5 Networks (FFIV) downgraded at Barclays to Equal Weight from Overweight. Checks suggest a blip in the rapid growth in server virtualization space in the near term. Price target raised to $95 from $90. Starwood Hotels (HOT) rated new Buy at Jefferies. $64 price target. Company owns key assets in larger urban and luxury markets. Penn National (PENN) numbers upped at Morgan Stanley. PENN estimates were boosted through 2011. Company is seeing better results in WV and PA. Overweight rating and new $38 price target. Penn National (PENN) upgraded at Jefferies from Hold to Buy. $41 price target. Company is performing well and faces easier near-term comps. Polycom (PLCM) estimates, target upped at UBS. PLCM estimates were boosted through 2011. Company is seeing better enterprise and government demand. Neutral rating and new $32 price target. Polycom (PLCM) upgraded at Wells to Outperform. Estimates also boosted, given the company's strong earnings momentum. Riverbed Technology (RVBD) target, estimates raised at Barclays. RVBD price target climbed to $50 from $38 on strong 3Q results with operating margins well ahead of estimates. 2010 and 2011 EPS estimates lifted to $1.15 and $1.50, respectively. Maintain Overweight rating. Riverbed Technology (RVBD) upgraded at Jefferies from Hold to Buy. $60 price target. Company is becoming a clear market leader in WAN optimization. Riverbed Technology (RVBD) upgraded at Canaccord from Hold to Buy. $60 price target. Company is realizing positive catalysts sooner than expected. Union Pacific (UNP) price target raised at Credit Suisse to $110 from $107. Strong 3Q results, due to higher pricing, topped estimates. Maintain Outperform rating. Union Pacific (UNP) upgraded at Wells to Outperform. Company continues to expand its margins, despite lower volumes. Union Pacific (UNP) downgraded at Baird from Outperform to Neutral. $93 price target. Volume growth is decelerating and incremental margins could moderate. URS (URS) rated new Buy at Keybanc. $50 price target. Stock is already pricing in fears of lower defense spending.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV